Michael Becka

6.7k citations
51 papers · 5.2k indexed · 5 hit papers · h-index 25

Impact in

    • Venous Thromboembolism Diagnosis and Management
    • Atrial Fibrillation Management and Outcomes
    • Cardiac Arrhythmias and Treatments
    • Antiplatelet Therapy and Cardiovascular Diseases
    • Cardiac electrophysiology and arrhythmias

Papers in

    • Venous Thromboembolism Diagnosis and Management 16
    • Atrial Fibrillation Management and Outcomes 24
    • Cardiac Arrhythmias and Treatments 7
    • Antiplatelet Therapy and Cardiovascular Diseases 6
    • Cardiac electrophysiology and arrhythmias 3

Michael Becka

51 papers receiving 5.0k citations

Hit Papers

Co‐administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects 2013 · 315 citations
3152004202620112018250500750

Peers

Michael Becka
Comparison fields: 5 of 115
  • Internal Medicine 2.8k
  • Cardiology and Cardiovascular Medicine 3.6k
  • Hepatology 694
  • Hematology 608
  • Pharmacology 263
Replace Gerhard Nehmiz with:
Gerhard Nehmiz Germany
Dagmar Kubitza Germany
Wolfgang Mueck Germany
John F. Paolini United States
Frank LaCreta United States
Sylvia Haas Germany
Joanne van Ryn Germany
S Coccheri Italy
Charles Frost United States
Karin Rathgen Germany
Michael Becka relative to Gerhard Nehmiz Germany Gerhard Nehmiz's profile →
Citations per field
00.5×4.5×
Gerhard Nehmiz · 1×
Citations per year

Countries citing papers authored by Michael Becka

Since Specialization
Citations

This map shows the geographic impact of Michael Becka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Becka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Becka more than expected).

Fields of papers citing papers by Michael Becka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Becka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Becka. The network helps show where Michael Becka may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Becka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Becka Line = papers co-authored together Michael Becka links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Serum markers detect the presence of liver fibrosis: A cohort study
Hit paper breakdown →
2004830
2
Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor
Hit paper breakdown →
2005512
3
Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects
Hit paper breakdown →
2005507
4
Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
Hit paper breakdown →
2013429
5 2010334
6
Co‐administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects
Hit paper breakdown →
2013315
7 2007271
8 2008215
9 2006198
10 2013160
11 2013159
12 2006148
13 2007142
14 2006130
15 2007118
16 201390
17 200670
18 200560
19 200154
20 200847

About Michael Becka

Michael Becka is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Hematology, Immunology and Allergy and Animal Science and Zoology, having authored 51 papers that have together received 5.2k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (24 papers), Venous Thromboembolism Diagnosis and Management (16 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers), Cardiac Arrhythmias and Treatments (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Vitamin K Research Studies (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). The work is most often cited by research in Internal Medicine (2.8k citations), Cardiology and Cardiovascular Medicine (3.6k citations), Hepatology (694 citations), Hematology (608 citations) and Pharmacology (263 citations). Michael Becka has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Dagmar Kubitza, Wolfgang Mueck, Michael Zuehlsdorf, Barbara Voith, Georg Wensing, Jan Stampfuss, Angelika Roth, Michael Voelker, William Rosenberg and Alastair D. Burt. Their work appears in journals such as Blood, British Journal of Clinical Pharmacology, The Journal of Clinical Pharmacology, European Respiratory Journal and Atherosclerosis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026